Therapeutic range of digoxin's efficacy in heart failure: What is the evidence?

Pharmacotherapy

Volumn 19, Issue 10, 1999, Pages 1123-1126

  Terra, Steven G ^a   Washam, Jeffrey B ^b   Dunham, Gary D ^b,c   Gattis, Wendy A ^c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b Campbell University   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; INOTROPIC AGENT; PLACEBO;

CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIGOXIN BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; SHORT SURVEY; SINUS RHYTHM;

CARDIOTONIC AGENTS; CLINICAL TRIALS; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HORMONES; HUMANS; NERVOUS SYSTEM;

EID: 0032868693     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.15.1123.30570     Document Type: Short Survey

References (19)

1. Beller GA, Smith TW, Abelmann WH, Haber E, Hood WB Jr. Digitalis intoxication: a prospective clinical study with serum level correlations. N Engl J Med 1971;284:989-97.
2. Packer MP, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993;329:1-7.
3. Uretsky BF, Young JB, Shahidi E, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cardiol 1993;22:955-62.
4. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
5. Klein M, Negad NS, Lown B, Hagemeijer, Barr I. Correlation of the electrical and mechanical changes in the dog heart during progressive digitalization. Circ Res 1971;29:635-45.
6. Packer M, Carver JR, Rodenheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991;325:1468-75.
7. The Xamoterol in Severe Heart Failure Study Group. Xamoterol in severe heart failure. Lancet 1990;336:1-6.
8. Feldman AM, Bristow MR, Parmley WW, et al. Effects of vesnarinone on morbidity and mortality in patients with heart failure. N Engl J Med 1993;329:149-55.
9. Dies F, Kiell MJ, Whitlow P, et al. Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure [abstr]. Circulation 1986;74(suppl II):II-38.
10. Cohn JN, Goldstein SO, Greenberg BH, et al. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Engl J Med 1998;339:1810-16.
11. Adams KF. Current perspectives on β-receptor antagonists in the treatment of symptomatic ventricular dysfunction. Pharmacotherapy 1996;16(suppl):69S-77.
12. Newton GE, Tong JH, Schofield AM, Baines AD, Floras JS, Parker JD. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. J Am Coll Cardiol 1996;28:155-61.
13. Frey B, Binder T, Teufelsbauer H, et al. Heart rate variability and patient outcome in advanced heart failure [abstr]. J Am Coll Cardiol 1993;21:286A.
14. Slatton ML, Irani WN, Hall SA, et al. Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol 1997;29:1206-13.
15. Gheorghiade M, Hall VB, Jacobsen G, Alam M, Rosman H, Goldstein S. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors. Circulation 1995;92:1801-7.
16. Adams KF, Gheorghiade M, Uretsky BF, Patterson JH, Schwartz TA, Young JB. Clinical benefits of low serum digoxin concentrations in heart failure [abstr]. J Am Coll Cardiol 1999;33:185A
17. Adams KF, Ellis ML, Williamson KM, Patterson JH. The AHCPR practice guideline for heart failure revisited. Ann Pharmacother 1997;31:1197-204.
18. Gheorghiade M, Pitt B. Digitalis investigation group (DIG) trial: a stimulus for further research. Am Heart J 1997;134:3-12.
19. Mancini DM, Benotti JR, Elkayam U, et al. Antiarrhythmic drug use and high serum levels of digoxin are independent adverse prognostic factors in patients with chronic heart failure [abstr]. Circulation 1991;84:II-243.